Gestion des effets secondaires des thérapies ciblées dans le cancer du rein : effets secondaires stomatologiques (mucites, épistaxis)
| Autor: | Scarlette Agbo-Godeau, Emmanuelle Nicolas-Virelizier, Florian Scotté |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Antifungal
Drug Cancer Research medicine.medical_specialty business.industry medicine.drug_class medicine.medical_treatment media_common.quotation_subject Cancer Hematology General Medicine medicine.disease Dietary advice Discovery and development of mTOR inhibitors Dermatology Targeted therapy Oncology Dental examination medicine Mucositis Radiology Nuclear Medicine and imaging business media_common |
| Zdroj: | Bulletin du Cancer. 98:S117-S126 |
| ISSN: | 0007-4551 |
| DOI: | 10.1684/bdc.2011.1439 |
| Popis: | The advent of targeted therapies in the treatment of renal cancer has shown different types of lesions of the oral cavity, which appear to be specific to the drug classes used (mTOR inhibitors, anti-angiogenic agents and conventional cytotoxic drugs). Before starting treatment with targeted therapy, it is essential to have an oral and a dental examination. The treatment of mucositis induced by targeted therapies is based on bicarbonate-based mouthwash, with the optional addition of an antifungal or a local antiseptic. It is possible to use topical or systemic analgesics for the pain. Dietary advice for patients is also useful. Most cases of epistaxis caused by anti-angiogenics stop spontaneously and require no medical intervention. Regular application of an emollient can be used to prevent the formation of scabs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|